Overview

Bioequivalence Fasting Study in Patients

Status:
Completed

Trial end date:
2014-06-01

Target enrollment:

Participant gender:

Summary

To compare and evaluate the oral bioavailability of Asenapine Sublingual Tablets, 10 mg manufactured by AMNEAL PHARMACEUTICALS, USA with SAPHRIS® (asenapine) sublingual tablets, 10 mg.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

Amneal Pharmaceuticals, LLC

Collaborator:

Accutest Research Laboratories (I) Pvt. Ltd.

Treatments:

Asenapine